BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 30870221)

  • 1. Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma.
    El-Maksoud MA; Habeeb MR; Ghazy HF; Nomir MM; Elalfy H; Abed S; Zaki MES
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):716-722. PubMed ID: 30870221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and Characteristics of Occult Hepatitis B Infection Among Hepatocellular Carcinoma Patients in Japan.
    Muto J; Sugiyama M; Shirabe K; Mukaide M; Kirikae-Muto I; Ikegami T; Yoshizumi T; Yamashita YI; Maehara Y; Mizokami M
    Ann Hepatol; 2018 July - August ,; 17(4):596-603. PubMed ID: 29893701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occult HBV infection in Morocco: from chronic hepatitis to hepatocellular carcinoma.
    Kitab B; Ezzikouri S; Alaoui R; Nadir S; Badre W; Trepo C; Chemin I; Benjelloun S
    Liver Int; 2014 Jul; 34(6):e144-50. PubMed ID: 24502524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study.
    Coppola N; Onorato L; Iodice V; Starace M; Minichini C; Farella N; Liorre G; Filippini P; Sagnelli E; de Stefano G
    Oncotarget; 2016 Sep; 7(38):62706-62714. PubMed ID: 27486882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C.
    Squadrito G; Cacciola I; Alibrandi A; Pollicino T; Raimondo G
    J Hepatol; 2013 Oct; 59(4):696-700. PubMed ID: 23751755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult hepatitis B virus infection is not associated with disease progression of chronic hepatitis C virus infection.
    Cho J; Lee SS; Choi YS; Jeon Y; Chung JW; Baeg JY; Si WK; Jang ES; Kim JW; Jeong SH
    World J Gastroenterol; 2016 Nov; 22(42):9427-9436. PubMed ID: 27895431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of occult hepatitis B virus infection in chronic hepatitis C.
    Coppola N; Onorato L; Pisaturo M; Macera M; Sagnelli C; Martini S; Sagnelli E
    World J Gastroenterol; 2015 Nov; 21(42):11931-40. PubMed ID: 26576082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological and Molecular Diagnosis of Occult Hepatitis B Virus Infection in Hepatitis C Chronic Liver Diseases.
    Daef EA; Makhlouf NA; Ahmed EH; Mohamed AI; Abd El Aziz MH; El-Mokhtar MA
    Egypt J Immunol; 2017 Jan; 24(1):37-48. PubMed ID: 29120576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of genotype D in chronic liver disease patients with occult HBV infection in northern region of India.
    Rizvi M; Azam M; Sultan A; Shukla I; Malik A; Ajmal MR; Khan F; Sami H
    Indian J Pathol Microbiol; 2014; 57(4):537-41. PubMed ID: 25308003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance.
    Mak LY; Wong DK; Pollicino T; Raimondo G; Hollinger FB; Yuen MF
    J Hepatol; 2020 Oct; 73(4):952-964. PubMed ID: 32504662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of hepatitis C virus with liver cirrhosis and hepatocellular carcinoma compared with hepatitis B virus in Egyptian patients.
    Darwish MA; Amer AF; El-Moeity AA; Darwish NM
    J Egypt Public Health Assoc; 1997; 72(5-6):569-89. PubMed ID: 17214153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma.
    Hernandez BY; Zhu X; Kwee S; Chan OT; Tsai N; Okimoto G; Horio D; McGlynn KA; Altekruse S; Wong LL
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2016-23. PubMed ID: 23983238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult HBV infection status among chronic hepatitis C and hemodialysis patients in Northeastern Egypt: regional and national overview.
    Mandour M; Nemr N; Shehata A; Kishk R; Badran D; Hawass N
    Rev Soc Bras Med Trop; 2015; 48(3):258-64. PubMed ID: 26108002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan.
    Marusawa H; Osaki Y; Kimura T; Ito K; Yamashita Y; Eguchi T; Kudo M; Yamamoto Y; Kojima H; Seno H; Moriyasu F; Chiba T
    Gut; 1999 Aug; 45(2):284-8. PubMed ID: 10403743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patients.
    El-Sherif A; Abou-Shady M; Abou-Zeid H; Elwassief A; Elbahrawy A; Ueda Y; Chiba T; Hosney AM
    J Gastroenterol; 2009; 44(4):359-64. PubMed ID: 19271112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma in Sweden: its association with viral hepatitis, especially with hepatitis C viral genotypes.
    Widell A; Verbaan H; Wejstål R; Kaczynski J; Kidd-Ljunggren K; Wallerstedt S
    Scand J Infect Dis; 2000; 32(2):147-52. PubMed ID: 10826899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.
    Ikeda K; Marusawa H; Osaki Y; Nakamura T; Kitajima N; Yamashita Y; Kudo M; Sato T; Chiba T
    Ann Intern Med; 2007 May; 146(9):649-56. PubMed ID: 17470833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.